Crossmark

Response to letters to editor "Next-Step Paradigms for Hepatitis B Functional Cure: Insights from the Anchor Combination Therapy Trial" and “Critical Appraisal of the Anchor RCT on Entecavir, Peginterferon Alfa-2b, and GM-CSF Combination Therapy”

Crossref DOI link: https://doi.org/10.1007/s12072-026-11055-x

Published Online: 2026-02-17

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wu, Di

Huang, Da

Yan, Weiming

Ning, Qin https://orcid.org/0000-0002-2027-9593
License Information

Text and Data Mining valid from 2026-02-17

Version of Record valid from 2026-02-17
More Information

Article History

Received: 12 January 2026

Accepted: 15 January 2026

First Online: 17 February 2026

Change Date: 9 April 2026

Change Type: Update

Change Details: The original online version of this article was revised to correct the title.

Declarations

:

: All the authors declare no conflict of interest.

Document is current

Any future updates will be listed below